FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Jun 21, 2016
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on June 21, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA Inc
- Inspection Date
- June 21, 2016
- Product Type
- Biologics
View Company Profile
ID · 71ad1ff9-7ae2-45dc-9e4e-68e38e7a6cce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 981277
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 630.40(a)Notification
- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 23, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 29, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 11, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 28, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc
- FDA Inspection 1111584 - 2019-10-23
- FDA Inspection 1029272 - 2017-08-29
- FDA Inspection 869727 - 2014-03-11
- FDA Inspection 756129 - 2011-10-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.